可表现为FDG高摄取并模仿恶性肿瘤的良性骨病变
本文综述了在18F-FDG PET检查中可表现为高摄取、易与恶性肿瘤混淆的多种良性骨病变,包括骨髓炎、良性系统性疾病相关骨病变、良性原发性骨病变及多种杂类良性骨病变;部分临床与影像学辅助表现有助于鉴别,但有时鉴别困难甚至不可能,需组织活检明确最终诊断。
要点
- FDG并非肿瘤特异性显像剂,多种良性骨病变可表现为FDG高摄取并模仿恶性肿瘤。
- 识别良性FDG高摄取骨病变的鉴别诊断有助于避免不必要的侵入性检查如骨活检。
- 部分临床与影像学辅助表现有助于鉴别良恶性,但有时鉴别困难甚至不可能,需组织活检。
核心结论
- 了解可模仿恶性肿瘤的良性FDG高摄取骨病变的鉴别诊断对正确患者管理很重要,包括避免不必要的额外侵入性检查如骨活检。
- 部分临床与影像学辅助表现有助于鉴别良性与恶性FDG高摄取骨病变,但有时鉴别困难甚至不可能,需获取组织以确立最终诊断。
研究设计与样本
- 综述,总结并图示可表现为FDG高摄取并模仿恶性肿瘤的良性骨病变谱。
主要发现
- 综述涵盖的良性骨病变包括骨髓炎、良性系统性疾病所致骨病变(棕色瘤、Erdheim-Chester病、戈谢病、痛风及其他类型关节炎、朗格汉斯细胞组织细胞增生症和结节病)、良性原发性骨病变(骨囊肿、软骨母细胞瘤、软骨黏液样纤维瘤、促结缔组织增生性纤维瘤、内生软骨瘤、巨细胞瘤和肉芽肿、血管瘤、非骨化性纤维瘤以及骨样骨瘤和骨母细胞瘤)以及一组杂类良性骨病变(骨髓活检或采集后状态、骨髓增生、纤维性结构不良、骨折、骨坏死、Paget骨病、颗粒病和Schmorl结节)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Positron emission tomography with the radiotracer 18F-fluoro-2-deoxy-d-glucose (FDG) plays an important role in the evaluation of bone pathology. However, FDG is not a cancer-specific agent, and knowledge of the differential diagnosis of benign FDG-avid bone alterations that may resemble malignancy is important for correct patient management, including the avoidance of unnecessary additional invasive tests such as bone biopsy. This review summarizes and illustrates the spectrum of benign bone conditions that may be FDG-avid and mimic malignancy, including osteomyelitis, bone lesions due to benign systemic diseases (Brown tumor, Erdheim-Chester disease, Gaucher disease, gout and other types of arthritis, Langerhans cell histiocytosis, and sarcoidosis), benign primary bone lesions (bone cysts, chondroblastoma, chondromyxoid fibroma, desmoplastic fibroma, enchondroma, giant cell tumor and granuloma, hemangioma, nonossifying fibroma, and osteoid osteoma and osteoblastoma), and a group of miscellaneous benign bone conditions (post bone marrow biopsy or harvest status, bone marrow hyperplasia, fibrous dysplasia, fractures, osteonecrosis, Paget disease of bone, particle disease, and Schmorl nodes). Several ancillary clinical and imaging findings may be helpful in discriminating benign from malignant FDG-avid bone lesions. However, this distinction is sometimes difficult or even impossible, and tissue acquisition will be required to establish the final diagnosis.
引用
- Kwee TC, de Klerk JMH, Nix M, et al. Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy. Semin Nucl Med. 2017. PMID: 28583274. doi:10.1053/j.semnuclmed.2017.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。